Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio Inc - Ordinary Shares - Class A

NUVB

Market Cap$807.76M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nuvation Bio Inc - Ordinary Shares - Class ANuvation Bio Inc - Ordinary Shares - Class A-1.2--106%--
$0.18

Current Fair Value

92.3% downside

Overvalued by 92.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$807.76 Million
Enterprise Value$801.86 Million
Dividend Yield$0 (0%)
Earnings per Share$-0.35
Beta1.36
Outstanding Shares273,565,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.23
PEG-1.12
Price to Sales-
Price to Book Ratio2.29
Enterprise Value to Revenue330.53
Enterprise Value to EBIT-5.96
Enterprise Value to Net Income-2
Total Debt to Enterprise0.03
Debt to Equity0.05

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Nuvation Bio Inc

36 employees

Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically ...